BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12455215)

  • 1. Benefit determination under managed care for substance abuse treatment clients.
    McNeese-Smith DK; Crook MW; Marinelli-Casey P; Williams L; Rawson R
    Care Manag J; 2001-2002 Winter; 3(2):55-62. PubMed ID: 12455215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed care and access to substance abuse treatment services.
    Alexander JA; Nahra TA; Wheeler JR
    J Behav Health Serv Res; 2003; 30(2):161-75. PubMed ID: 12710370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public managed care and service access in outpatient substance abuse treatment units.
    Chuang E; Wells R; Alexander JA
    J Behav Health Serv Res; 2011 Oct; 38(4):444-63. PubMed ID: 21184286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and costs of substance abuse services within The HMO Group.
    Levin BL
    HMO Pract; 1993 Mar; 7(1):28-34. PubMed ID: 10171407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The administrative control system of substance abuse managed care.
    Sosin MR
    Health Serv Res; 2005 Feb; 40(1):157-76. PubMed ID: 15663707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using health insurance claims data to analyze substance abuse charges and utilization.
    Garnick DW; Horgan CM; Hendricks AM; Comstock C
    Med Care Res Rev; 1996 Sep; 53(3):350-68. PubMed ID: 10172725
    [No Abstract]   [Full Text] [Related]  

  • 9. The sensitivity of substance abuse treatment intensity to co-payment levels.
    Lo Sasso AT; Lyons JS
    J Behav Health Serv Res; 2004; 31(1):50-65. PubMed ID: 14722480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of case management in the publicly funded substance abuse treatment system. The perspective of program directors, case managers and clients.
    Shwartz M; Stone DA; Camp J; Mulvey KP; Kane M; Plough A
    Care Manag J; 2000; 2(3):139-47. PubMed ID: 11398569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care.
    Stein B; Orlando M; Sturm R
    Psychiatr Serv; 2000 Feb; 51(2):195-8. PubMed ID: 10655002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving publicly funded substance abuse treatment: the value of case management.
    Shwartz M; Baker G; Mulvey KP; Plough A
    Am J Public Health; 1997 Oct; 87(10):1659-64. PubMed ID: 9357349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care for substance abuse treatment: impact in Iowa.
    Rohrer JE; Rohland BM; Westermann J; Knott A; Zwick J
    Adm Policy Ment Health; 1999 Jul; 26(6):429-33. PubMed ID: 10615744
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the receipt of treatment following detoxification.
    Mark TL; Dilonardo JD; Chalk M; Coffey R
    J Subst Abuse Treat; 2003 Jun; 24(4):299-304. PubMed ID: 12867203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating managed mental health programs.
    Whitted GS; Kunnes R
    AAPPO J; 1993; 3(2):27-30. PubMed ID: 10171662
    [No Abstract]   [Full Text] [Related]  

  • 20. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.